Related Experiment Video
Updated: Jul 18, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Trends in Pneumococcal and Bacterial Meningitis in Brazil from 2007 to 2019
Cintia Irene Parellada1, Ariane de Jesus Lopes de Abreu2, Marina G Birck2
1MSD Brazil, São Paulo 04583-110, Brazil.
Insights
Pneumococcal conjugate vaccination (PCV) reduced meningitis in Brazilian children but increased in adults. Expanding vaccination to older adults is recommended to reduce disease burden.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Pneumococcal conjugate vaccination (PCV) was implemented in Brazil's childhood program in 2010.
- Universal pneumococcal vaccination for older adults remains unaddressed.
- Streptococcus pneumoniae is a leading cause of bacterial meningitis, particularly in adults.
Purpose of the Study:
- To analyze trends in pneumococcal meningitis incidence and case fatality rates (CFR) across all age groups in Brazil from 2007 to 2019.
- To compare pre-PCV and post-PCV periods to assess the impact of vaccination.
- To examine trends in overall bacterial meningitis to contextualize pneumococcal meningitis data.
Main Methods:
- Utilized data from Brazil's National Surveillance System for bacterial and pneumococcal meningitis cases (2007-2019).
- Employed joinpoint regression to analyze changes in incidence and CFR between pre-PCV (2007-2009) and post-PCV (2011-2019) periods.
- Conducted comparative analyses of bacterial meningitis patterns and trends.
Main Results:
- Over 13 years, 81,203 bacterial and 13,837 pneumococcal meningitis cases were recorded.
- Post-PCV introduction, a 56.5% decrease in pediatric pneumococcal meningitis incidence was observed.
- Adults showed an increasing trend in pneumococcal meningitis incidence, while CFR remained stable across most age groups.
Conclusions:
- PCV significantly reduced pneumococcal meningitis in Brazilian children.
- Increasing incidence in adults suggests a need for expanded vaccination strategies.
- Recommendations include broadening PCV to older adults and utilizing vaccines with enhanced indirect protection.
Abstract:
The pneumococcal conjugate vaccination (PCV) was introduced into the Brazilian Childhood National Immunization Program in 2010; however, universal pneumococcal vaccination for older adults has not been implemented yet. Our aim is to evaluate the trends in pneumococcal meningitis incidence and case fatality rate (CFR) across all age groups from 2007 to 2019 using data from the National Surveillance System. The pre-PCV (2007-2009) and post-PCV (2011-2019) periods were compared; changes in incidence and CFR were assessed by joinpoint regression. Additional analyses of bacterial meningitis were performed to compare the patterns and trends. Over the 13-year period, 81,203 and 13,837 cases were classified as bacterial and pneumococcal meningitis, respectively. S. pneumoniae was the main etiological agent of bacterial meningitis in adults aged ≥50 years and the most lethal in all age groups. In the post-PCV period, a 56.5% reduction in the average incidence was seen in pneumococcal meningitis in the pediatric population. In contrast, there was an increasing trend among adults. The CFR for pneumococcal and bacterial meningitis remained stable in most age groups during the study period. These findings highlight the value of expanding pneumococcal vaccination policies, including vaccines that provide better indirect protection from children to adults and broadening vaccination to older adults.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

